# Huons receives FDA approval for 2% lidocaine injection

Huons received FDA ANDA approval for its 2% lidocaine injection 5mL vial, a local anesthetic, and is expanding production lines at its Jecheon 2 plant with a 24.5 billion won investment to increase vial and cartridge capacity.

- Type: Product launch
- Announced: 2023-06-19
- Where: Jecheon, South Korea
- Value: $19.0M (24.5B KRW)
- Status: announced
- Capacity: 79 million vials (new vial line), 201 million cartridges (new cartridge line)
- Products: 2% lidocaine injection, vial, cartridge injection
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Huons](https://endata.com/companies/51458.md)

## Sources

- [thevaluenews.co.kr](https://www.thevaluenews.co.kr/news/176491), 2023-06-19: "휴온스는 미국 FDA로부터 2% 리도카인주사제 5mL 바이알에 대한 의약국 품목허가(ANDA) 승인을 획득했다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.